NEW YORK (Reuters Health) – Warfarin dosing based on genotype-stratified tables is more accurate than empiric dosing, but not as good as estimates derived from formal pharmacogenetic algorithms,…
NEW YORK (Reuters Health) – A high loading dose of clopidogrel — 600 mg — appears to be unnecessary in Asian patients with ST-segment elevation myocardial infarction (STEMI)…
NEW YORK (Reuters Health) – The clinical efficacy of rituximab in rheumatoid arthritis (RA) depends on the degree of B cell depletion rather than the dose of rituximab,…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…
NEW YORK (Reuters Health) – Results of a large randomized, double-blind study suggest that the TNF inhibitor etanercept (Enbrel; Pfizer) may be more efficacious than sulfasalazine in the…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD), an impaired platelet response clopidogrel independently contributes to worse outcomes after percutaneous coronary intervention (PCI), a…
NEW YORK (Reuters Health) – Sumatriptan given subcutaneously relieves cyclic vomiting syndrome associated with migraine, researchers from Japan report in the December 8th online Cephalalgia. “Try sumatriptan for…
NEW YORK (Reuters Health) – The proton pump inhibitor dexlansoprazole modified release (MR) relieves nocturnal heartburn in patients with gastroesophageal reflux disease (GERD), study findings show. As a…
NEW YORK (Reuters Health) – After a first myocardial infarction, treatment with a calcium-channel blocker (CCB) does not appear to diminish the efficacy of clopidogrel, according to results…
NEW YORK (Reuters Health) – Depending on the particular regimen, insulin analogs can help 35% to 64% of patients with type 2 diabetes achieve the recommended hemoglobin A1C…